These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 29017702
1. Collaborative study on saccharide quantification of the Haemophilus influenzae type b component in liquid vaccine presentations. Rosskopf U, Daas A, Terao E, von Hunolstein C. Pharmeur Bio Sci Notes; 2017; 2017():44-68. PubMed ID: 29017702 [Abstract] [Full Text] [Related]
2. Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide. Mawas F, Bolgiano B, Rigsby P, Crane D, Belgrave D, Corbel MJ. Biologicals; 2007 Oct; 35(4):235-45. PubMed ID: 17337205 [Abstract] [Full Text] [Related]
3. International collaborative study for establishment of the 2nd WHO International Standard for Haemophilus influenzae type b polysaccharide. Mawas F, Burkin K, Dougall T, Saydam M, Rigsby P, Bolgiano B, Hib PRP IS Working Group. Biologicals; 2015 Nov; 43(6):492-503. PubMed ID: 26298195 [Abstract] [Full Text] [Related]
4. Quantitative determination of saccharide in Haemophilus influenzae type b glycoconjugate vaccines, alone and in combination with DPT, by use of high-performance anion-exchange chromatography with pulsed amperometric detection. Bardotti AA, Ravenscroft NN, Ricci SS, D'Ascenzi SS, Guarnieri VV, Averani GG, Constantino PP. Vaccine; 2000 Apr 03; 18(19):1982-93. PubMed ID: 10706959 [Abstract] [Full Text] [Related]
5. High performance anion exchange chromatographic and colorimetric methods for quality assessment of total and free polysaccharide content in Haemophilus influenzae type b conjugate vaccine containing lactose. Hussein AR, Rezk MR, Fathalla FAA, El-Saharty YS, Nadim AH. Anal Methods; 2022 Oct 06; 14(38):3757-3765. PubMed ID: 36106712 [Abstract] [Full Text] [Related]
6. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L. Pediatr Infect Dis J; 2006 Aug 06; 25(8):706-12. PubMed ID: 16874170 [Abstract] [Full Text] [Related]
7. HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples. van der Put RM, de Haan A, van den IJssel JG, Hamidi A, Beurret M. Vaccine; 2015 Nov 27; 33(48):6908-13. PubMed ID: 25045809 [Abstract] [Full Text] [Related]
9. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines. Gupta RK, Anderson R, Cecchini D, Rost B, Griffin P, Benscoter K, Xu J, Montanez-Ortiz L, Siber GR. Dev Biol Stand; 1996 Nov 27; 86():283-96. PubMed ID: 8785957 [Abstract] [Full Text] [Related]
11. Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine. An SJ, Woo JS, Chae MH, Kothari S, Carbis R. Vaccine; 2015 Mar 24; 33(13):1614-9. PubMed ID: 25659268 [Abstract] [Full Text] [Related]
15. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components. Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D. Int J Infect Dis; 2008 May 24; 12(3):278-88. PubMed ID: 17981067 [Abstract] [Full Text] [Related]
16. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. Goldblatt D, Richmond P, Millard E, Thornton C, Miller E. J Infect Dis; 1999 Aug 24; 180(2):538-41. PubMed ID: 10395878 [Abstract] [Full Text] [Related]